Marlena Walls

Drug Discovery Laboratory (Norway) — Norway

Medicine · Health Sciences

11h-index552citations75works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Research Studies(27), PI3K/AKT/mTOR signaling in cancer(19), MicroRNA in disease regulation(13), Lung Cancer Treatments and Mutations(12), Computational Drug Discovery Methods(10)

Publications75 total

Supplementary Figure 4S from Lipid Nanoparticle–Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth
2023Open Access
Data from Lipid Nanoparticle–Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth
2023Open Access
Supplementary Figure 2S from Lipid Nanoparticle–Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth
2023Open Access
Supplementary Figure 3S from Lipid Nanoparticle–Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth
2023Open Access
Supplementary Figure 2S from Lipid Nanoparticle–Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth
2023Open Access
Supplementary Figure 1S from Lipid Nanoparticle–Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth
2023Open Access
Supplementary Figure 1S from Lipid Nanoparticle–Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth
2023Open Access
Supplementary Figure 4S from Lipid Nanoparticle–Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth
2023Open Access
Supplementary Methods and legends from Lipid Nanoparticle–Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth
2023Open Access
Data from Lipid Nanoparticle–Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth
2023Open Access
Supplementary Methods and legends from Lipid Nanoparticle–Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth
2023Open Access
Supplementary Figure 3S from Lipid Nanoparticle–Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth
2023Open Access
Supplementary Figure S1 from Targeting Small Cell Lung Cancer Harboring <i>PIK3CA</i> Mutation with a Selective Oral PI3K Inhibitor PF-4989216
2023Open Access
Supplementary Figure S5 from Targeting Small Cell Lung Cancer Harboring <i>PIK3CA</i> Mutation with a Selective Oral PI3K Inhibitor PF-4989216
2023Open Access
Supplementary Table 3 from Evaluation of Selective γ-Secretase Inhibitor PF-03084014 for Its Antitumor Efficacy and Gastrointestinal Safety to Guide Optimal Clinical Trial Design
2023Open Access
Supplementary Table SI from Targeting Small Cell Lung Cancer Harboring <i>PIK3CA</i> Mutation with a Selective Oral PI3K Inhibitor PF-4989216
2023Open Access
Data from Targeting Small Cell Lung Cancer Harboring <i>PIK3CA</i> Mutation with a Selective Oral PI3K Inhibitor PF-4989216
2023Open Access
Supplementary Table SIII from Targeting Small Cell Lung Cancer Harboring <i>PIK3CA</i> Mutation with a Selective Oral PI3K Inhibitor PF-4989216
2023Open Access
Supplementary Figure S8 from Targeting Small Cell Lung Cancer Harboring <i>PIK3CA</i> Mutation with a Selective Oral PI3K Inhibitor PF-4989216
2023Open Access
Supplementary Figure S1 from Targeting Small Cell Lung Cancer Harboring <i>PIK3CA</i> Mutation with a Selective Oral PI3K Inhibitor PF-4989216
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Tod Smeal(32), Min-Jean Yin(30), Sangita M. Baxi(27), Heather Estrella(26), Pramod P. Mehta(24), Chunze Li(23), JinJiang Zhu(21), Kevin K.‐C. Liu(20), Qing Zong(18), Michael L. Zientek(17), Xinqiang Huang(7), Jill Magnus(7), Vivek Kaimal(7), Priya Karmali(7), Rene Prudente(7), Eric Sung(7), Mehran Sorourian(7), Edmund C. Lee(7), Adam Pavlı́c̀ek(7), Sonya Zabludoff(7)